FSD Pharma to Begin Trading on the NASDAQ Capital Market Under Symbol ‘HUGE’ on January 9, 2020
TORONTO–(BUSINESS WIRE)–#FSDDF—FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD Pharma” or the “Company”) today announced that its Class…
Pharmaceuticals, Biotechnology and Life Sciences
TORONTO–(BUSINESS WIRE)–#FSDDF—FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD Pharma” or the “Company”) today announced that its Class…
Glass Lewis States “[W]e Believe the Current [CGP/Sirtex Transaction] Proposal Warrants Investor Support”; Provides Detailed Critique of Alpha’s “Murky” Financing…
MARIETTA, Ohio–(BUSINESS WIRE)–#AAGP–ProtoKinetix, Incorporated (www.protokinetix.com) (the “Company” or “ProtoKinetix”) (OTCQB:PKTX) announces that ITR Laboratories of Montreal have run multiple tests…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of immune…
Sole Representative from the Pharmaceutical Industry BEIJING–(BUSINESS WIRE)–CANbridge Pharmaceuticals Inc., a biopharmaceutical company developing innovative drug candidates to treat underserved…
TOKYO & BASKING RIDGE, N.J.–(BUSINESS WIRE)–Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that ENHERTU® (fam-trastuzumab deruxtecan-nxki), a HER2…
BOSTON–(BUSINESS WIRE)–Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) and Allergan plc (NYSE: AGN) announced today that the companies have reached an agreement…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Relay Therapeutics, a new breed of company at the intersection of computation and biotechnology, today announced that Sanjiv…
BURTON UPON TRENT, England–(BUSINESS WIRE)–Clinigen Group plc (AIM: CLIN, ‘Clinigen’), the global pharmaceutical and services company, has partnered with Orphazyme…
BOTHELL, Wash.–(BUSINESS WIRE)–Seattle Genetics, Inc. (Nasdaq:SGEN) announced today that management will present at the 38th Annual J.P. Morgan Healthcare Conference…